
Sign up to save your podcasts
Or


Moderna, Pfizer and now Johnson & Johnson have emerged as surprising heroes of the Covid-19 pandemic—pulling our nation out of this pandemic one vaccine shot at a time.
This week, however, co-host Jeremy Corr raised a thought-provoking question: Why aren’t generic drug makers getting involved to help speed up vaccine production and end this pandemic faster? Do name-brand drug companies have any obligation to hand over their patents to generic drug manufacturers? Would it make a difference if they did?
In this episode of Coronavirus: The Truth, Jeremy and Dr. Robert Pearl discuss the ethical and legal implications of drug development during a national crisis.
Here’s everything that was discussed [and when] on this episode:
[00:55] Each week, the show begins with the most recent and relevant facts of the COVID-19 pandemic and its impact on American life. What’s happening and what does it mean?
[05:20] Listener question: “We seem to be learning more about the Covid-19 vaccines each week. Is anything still uncertain?”
[12:40] Who’s still hesitant to take the vaccine and why?
[15:15] Nursing homes were responsible for approximately 40% of deaths in the early phases of the pandemic. What about now?
[16:50] Listener question: “How does the mutation rate of this virus compares to others we’ve seen in the past?”
[20:00] Pfizer has requested FDA approval to meet less stringent storage and transportation requirements. What happened with that?
[21:03] Why aren’t drug companies required to hand over their patents to generic drug manufacturers in order to speed up production and end the pandemic?
[23:52] Any especially good news this week?
[25:57] Mental health remains a major worry for educators and parents. What are we learning?
[27:54] Any new insights on the origin of the virus one year later?
[30:50] Some states like Texas are talking about eliminating any Covid-related restrictions whereas officials like Dr. Fauci describe these as foolish and dangerous actions. Discuss …
[36:00] Obesity is known as a major contributor to complications and deaths from Covid-19. Why is America’s weight problem only treated as a wake-up call?
This episode is available on Apple Podcasts, Google Play, Spotify and other podcast platforms.
If you have coronavirus questions for the hosts, please visit the contact page or send us a message on Twitter or LinkedIn.
*To ensure the credibility of this program, Coronavirus: The Truth refuses to accept sponsorship, outside funding sources or guests with any financial or personal conflicts of interest.
The post CTT #33: Why aren’t we producing generic vaccines? appeared first on Fixing Healthcare.
By Robert Pearl and Jeremy Corr4.5
159159 ratings
Moderna, Pfizer and now Johnson & Johnson have emerged as surprising heroes of the Covid-19 pandemic—pulling our nation out of this pandemic one vaccine shot at a time.
This week, however, co-host Jeremy Corr raised a thought-provoking question: Why aren’t generic drug makers getting involved to help speed up vaccine production and end this pandemic faster? Do name-brand drug companies have any obligation to hand over their patents to generic drug manufacturers? Would it make a difference if they did?
In this episode of Coronavirus: The Truth, Jeremy and Dr. Robert Pearl discuss the ethical and legal implications of drug development during a national crisis.
Here’s everything that was discussed [and when] on this episode:
[00:55] Each week, the show begins with the most recent and relevant facts of the COVID-19 pandemic and its impact on American life. What’s happening and what does it mean?
[05:20] Listener question: “We seem to be learning more about the Covid-19 vaccines each week. Is anything still uncertain?”
[12:40] Who’s still hesitant to take the vaccine and why?
[15:15] Nursing homes were responsible for approximately 40% of deaths in the early phases of the pandemic. What about now?
[16:50] Listener question: “How does the mutation rate of this virus compares to others we’ve seen in the past?”
[20:00] Pfizer has requested FDA approval to meet less stringent storage and transportation requirements. What happened with that?
[21:03] Why aren’t drug companies required to hand over their patents to generic drug manufacturers in order to speed up production and end the pandemic?
[23:52] Any especially good news this week?
[25:57] Mental health remains a major worry for educators and parents. What are we learning?
[27:54] Any new insights on the origin of the virus one year later?
[30:50] Some states like Texas are talking about eliminating any Covid-related restrictions whereas officials like Dr. Fauci describe these as foolish and dangerous actions. Discuss …
[36:00] Obesity is known as a major contributor to complications and deaths from Covid-19. Why is America’s weight problem only treated as a wake-up call?
This episode is available on Apple Podcasts, Google Play, Spotify and other podcast platforms.
If you have coronavirus questions for the hosts, please visit the contact page or send us a message on Twitter or LinkedIn.
*To ensure the credibility of this program, Coronavirus: The Truth refuses to accept sponsorship, outside funding sources or guests with any financial or personal conflicts of interest.
The post CTT #33: Why aren’t we producing generic vaccines? appeared first on Fixing Healthcare.

4,279 Listeners

285 Listeners

2,435 Listeners

499 Listeners

609 Listeners

1,459 Listeners

9,203 Listeners

613 Listeners

189 Listeners

896 Listeners

397 Listeners

8,194 Listeners

146 Listeners

58 Listeners

344 Listeners